top of page

Resveratrol Research Project

Benefit Research:  NAD+ | NADH | SIRT1 | NMN

A natural compound Resveratrol(Rsv), which is found in high concentrations in grape skins and red wine, is expected to be a leading drug for elongating the life span and preventing oncogenesis. This compound is reported to have various beneficial effects on health, including the activation of complex I and antioxidants stress. We have been focusing on the regulation of the expression of human genes and have analyzed the promoter activities of several genes that encode DNA repair function-associated protein factors. The molecular mechanism by which Rsv regulates the expression of genes associated with DNA Repair.

resveratrol 2.jpg

 David Sinclair, Ph.D.: Slowing aging – sirtuins, NAD, and the epigenetics of aging

We suggest the possibility of developing new anti-aging/cancer drugs without harmful side effects, based on a new concept of ameliorating or maintain the cellular NAD+/NADH Level, NMN:

  • Rsv: trans-resveratrol

  • Activates SIRT1, which is NAD+ dependent deacetylase.

  • Benefits: Anti-aging, Rejuvenation, High Antioxidant, DNA-Repair, avoid heart disease & anti-cancer.

  • The supplements mixtures with NAD+ & NMN [Anti-Aging & DNA Repair]

  • Antivirus for NMN, Longevity, Produce new proteins, Reverse DNA Damage*

Global Biotechnology Market 2026 | Bio Innovation 

The Global biotechnology market was valued at USD 436.14 million in 2019 and expected to reach USD665.68 million by 2026, growing at a CAGR of 6.23% over the forecast period. Increasing prevalence of conditions, for in stance, hepatitis B disease, and other issues is anticipated to fuel the global biotechnology market growth. 

The market has been segmented on the basic of type, application and region. Type segment includes nano-biotechnology, DNA sequencing, fermentation, PCR technology, cell-based assay, chromatography, tissue engineering and regeneration and others. The nan-biotechnology segment held the largest market share of 22.97% in 2019. For chronic diseases such as cancer, nano-biotechnology finds major use in drug delivery therapies. It includes the development of nanoparticle-based chemotherapeutic drugs, gold nanoparticles, and quantum dots for molecular diagnosis and nan biosensors which help in optical imaging and drug delivery. 

Application segment includes agriculture, industrial processing, pharmacy, bioinformatics, environment, Bio services and others. The pharmacy segment held the largest market share of 27.29% and valued at USD 119.24 million in 2019. Increasing usage of bio-recombinant proteins in different vaccines used to treat chronic and infectious diseases is anticipated to fuel the segment growth. 

The market has been divided into North America, Europe, Asia Pacific, South America and middle East and Africa. North America held the largest market share of 38.09% and valued at USD 166.13 million in 2019. The presence of high R&D investments pertaining to new drug discovery and development are some factors which attributed to this large share. The U.S. spends more per capital on healthcare than other countries and has a high growth rate amongst other countries. According to the estimates published by OECD Health Statistics in 2014, it has been estimated than in 2012, the U.S. spend nearly 16.9% of its GDP on healthcare expenditure, which was the highest. The aforementioned fact supports the estimated share of the global biotechnology market. The market for global biotechnology market is segmented into key players. Major players include Bio-rad laboratories, PerkinElmer, Johnson & Johnson Services Inc, Thermo Fisher Scientific, Agilent Technologies, Sanofi, Abbott Laboratories, Qiagen, Pfizer among others. Abbott Laboratories held the largest market share of 14.69% in 2019. 


bottom of page